Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06121986 · ClinicalTrials.gov registry record · NA

A Scalable Nutrition Adherence Intervention

A NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by Florida State University.

Active
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT06121986: Active NA study of Alzheimer Disease and Mild Cognitive Impairment, sponsored by Florida State University.

NCT06121986 is a NA study of Alzheimer Disease and Mild Cognitive Impairment that is active but no longer recruiting, run by Florida State University. The registered enrollment target is 61 participants, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06121986, a NA study of Alzheimer Disease and Mild Cognitive Impairment, is active but no longer recruiting, sponsored by Florida State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

Objective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida. The investigators hypothesize that: 1\. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., good adherence) in the Modified Mediterranean-Ketogenic diet (MMKD) group and an average score of \>6 on the MEDAS questionnaire in the Mediterranean group during the 10-week program. Further, we hypothesize that the use of ongoing monthly support groups will bolster long-term adherence. Objective 2: To evaluate the effects of adherence to Mediterranean versus MMKD on novel gut-brain axis markers of Alzheimer's disease pathogenesis in individuals with mild cognitive impairment compared to cognitively normal older adults. The investigators hypothesize that individuals with mild cognitive impairment will: 1. Have greater evidence of gut dysbiosis at baseline than cognitively normal controls and 2. Will demonstrate greater increases in beneficial gut microbial metabolites in response to adherence to Mediterranean-Ketogenic nutrition and the Mediterranean diet compared to CN controls.

Primary Outcome

Participants will show measurable levels of ketones using at-home urinalysis test strips by week 10 of the intervention, as evidenced by small trace amounts of ketones on the urine strips.

Interventions

  • BEHAVIORAL Improving Cognitive Aging through Nutrition (ICAN) Adherence Program
  • BEHAVIORAL Improving Cognitive Aging through Nutrition, Mediterranean diet

Study Locations (1)

Florida

  • 2010 Levy Ave - Center for Translational Behavioral Science - Tallahassee

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2023-11-30
Est. Completion 2026-05
Phase NA
Florida State University

219 total trials

What the registry record for NCT06121986 still lists

NCT06121986 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 2,751-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (98% lower).

The record links to 3 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 2 interventions - of which Improving Cognitive Aging through Nutrition (ICAN) Adherence Program is the first listed.

NCT06121986 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06121986 about?

NCT06121986 is a clinical study titled "A Scalable Nutrition Adherence Intervention". Objective 1: To scale-up the nutrition adherence intervention for testing in racially diverse rural communities in North Florida. The investigators hypothesize that: 1\. The protocol will produce at least 75% of participants obtaining measurable levels of urine ketones (e.g., good adherence) in th...

What is the current status of trial NCT06121986?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 61 participants. The study started on 2023-11-30. Estimated completion is 2026-05.

What conditions does trial NCT06121986 study?

This clinical trial studies the following conditions: Alzheimer Disease, Mild Cognitive Impairment, Adherence.

What interventions are being tested in trial NCT06121986?

The interventions under investigation include: Improving Cognitive Aging through Nutrition (ICAN) Adherence Program (BEHAVIORAL), Improving Cognitive Aging through Nutrition, Mediterranean diet (BEHAVIORAL).

Who is sponsoring clinical trial NCT06121986?

This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06121986 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06121986's enrollment target sits among peer trials

61 185th of 306 higher than 121 of 306 other Alzheimer Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alzheimer Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06121986, the US trial registry maintained by the National Library of Medicine. NCT06121986 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.